BioNTech says European Patent Office has declared Moderna patent invalid

COVID-19 vaccine maker BioNTech said on Tuesday the European Patent Office has declared as invalid an mRNA patent that has been invoked by Moderna in litigation about alleged an patent violation by BioNTech and its partner Pfizer.
"We understand and welcome the European Patent Office’s decision to revoke Moderna’s European Patent 3 718 565 B1," the German biotech firm said in…

This story appeared on, 2023-11-21.
Read the Entire Internet on a Single Page. Join Now →